Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection

NCT04838626 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms
Prostate Cancer

Interventions

DRUG: [18F]CTT1057

Sponsor

Novartis Pharmaceuticals